鼻过敏
- 网络nasal allergy
-
在该研究中,一些因素与较高的鼻过敏罹患风险有关,比如家庭过敏史与母亲怀孕时抽菸都是证据充分的风险因子。
A number of factors were linked to a higher risk of nasal allergies in the study . Some , like a family history of allergies and the mother smoking while pregnant , are well documented risk factors .
-
方法用TDI致豚鼠过敏性鼻炎造模型,观察敏停喷鼻剂对过敏性鼻炎模型的鼻部过敏症状以及鼻黏膜病理组织形态学的影响。
METHODS The hypersensitive symptoms of nasal part and the effects on pathohistology of nasal mucosa were observed by copying animal model of allergic rhinitis .
-
曲安奈德鼻喷雾剂治疗过敏性鼻炎的临床研究
Clinical Study of Treatment of Allergia Rhinitis with Triamcinolone Acetonide Nasal Spray
-
结论敏停喷鼻剂对过敏性鼻炎可能具有较好的疗效。
CONCLUSIONS Minting nasal spray has potential therapeutical effect on allergic rhinitis .
-
重组人干扰素ω喷鼻剂治疗过敏性鼻炎的近期疗效观察
Effect of nasal spray of recombinant human interferon - ω on allergic rhinitis
-
氮卓斯丁喷鼻剂治疗过敏性鼻炎的临床疗效观察
Clinical trial report of azelastine nasal spray in the treatment of allergic rhinitis
-
结论:曲安奈德鼻喷雾剂治疗过敏性鼻炎安全有效。
CONCLUSION : Triamcinolone acetonide nasal spray is effective and safe in treatment of allergia rhinitis .
-
鼻鼽散治疗过敏性鼻炎54例
Bi Qiu Powder in Treatment of 54 Cases with Rhinallergosis
-
经鼻吸入布地奈德治疗过敏性鼻炎-哮喘综合征
Treatment of combined allergic rhinitis and asthma syndrome by nasal inhalation of budesonide
-
目的研究敏停喷鼻剂对豚鼠过敏性鼻炎模型的影响。
OBJECTIVE To investigate the effect of Minting nasal spray on allergic rhinitis model induced by TDI .
-
目的观察三伏天穴位敷贴配合益气健鼻汤综合治疗过敏性鼻炎的临床疗效。
Objective To observe the therapeutic effect of point application combined with " Yiqi Jianbi Decoction " in the dog-days on allergic rhinitis .
-
结论:针刺穴位对过敏性鼻炎有治疗效果;针刺穴位联合布地奈德喷鼻剂用于治疗过敏性鼻炎的效果优于单纯针刺穴位或单纯用布地奈德喷鼻剂。
Therapeutic effect of acupuncture combined with budesonide nasal spray for allergic rhinitis was better than that of acupuncture alone or that of budesonide nasal spray alone .
-
广东省中山市城区6~12岁学龄儿童鼻眼气道皮肤过敏症状的问卷调查分析
Questionnaire survey on the anaphylaxis of nose , eyes , airway and skin in urban school children aged from 6 to 12 years in Zhongshan , Guangdong Province
-
其中哮喘-鼻息肉-阿司匹林过敏三联症的发病率(19例,6.5%)亦明显高于Ⅰ组(3例,1.0%)。
Incidence of triad ( asthma-nasal polyp and aspirin-allergy ) was 6.5 % ( 19 / 291 ) in the Group ⅱ, significantly higher than that in the Group ⅰ ( 1.0 % , 3 / 292 ) .